Our immune systems generate antibodies that neutralize and help eliminate foreign pathogens. These antibodies or proteins are generated by specific immune cells, which then recognize and bind to ...

Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared ...

Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists. Monoclonal ...

A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists. Subscribe to our newsletter for the latest sci-tech news ...

Cryo-electron microscope reconstruction of the binding of a human anti-PcrV Fab antibody (yellow) to a PcrV pentamer (blue) of the type III secretion system (T3SS) of Pseudomonas aeruginosa. The ...

Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognize a sugar found only on bacterial cells—an advance that could ...

Could monoclonal antibodies be the key to tackling the growing problem of antimicrobial resistance? A team led by researchers at the University of Cambridge has developed a monoclonal antibody drug ...

One of the most lethal forms of breast cancer has long shrugged off the best drugs in the oncologist’s arsenal, leaving patients with few options once standard treatments fail. Now a new generation of ...

Our findings suggest that RAS amplification may confer resistance to anti-EGFR antibodies. Assessing RAS amplification status can help clinicians identify patients who may have a reduced benefit from ...

Graphic showing ‘triple-engineered antibody’, latches onto cancer cells on one end and draws in immune cells on the other. A new potential antibody therapy strategy which restricts the growth of ...